Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

IDRA

Idera Pharmaceuticals (IDRA)

Idera Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:IDRA
일자시간출처헤드라인심볼기업
2023/06/3005:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/06/2408:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/05/1722:50Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/05/1606:08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/05/1305:25Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/04/1405:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/04/1105:41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/04/0319:00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/03/3105:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/03/2900:29Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/03/2900:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/02/1507:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/02/0406:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/02/0206:44Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/3106:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1906:55Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1906:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1722:00GlobeNewswire Inc.Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookNASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1322:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2023/01/1122:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/12/2307:21Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/12/1006:50Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/2406:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1807:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1506:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1506:58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/11/1506:05GlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
2022/10/0605:36Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/10/0406:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
2022/10/0105:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:IDRA